Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA

Latest

The Vitamin Shoppe powers the “Old Glory Ultra Relay” with Team RWB to support vets
Powered by nutrition and supplement formulas from BodyTech, JOCKO FUEL, RAW Nutrition, REDCON1, and 1st Phorm, 12 elite runners come together to run an American flag across the U.S in record time.

The CPG Guys: Lower Your EPS Targets Significantly! with RBC Capital Markets’ Nik Modi
The CPG Guys are joined by Nik Modi, co-head of global consumer and retail research at RBC Capital Markets.

EG America Launches Retail Media Network Capabilities with Axonet
EG America’s RMN empowers brands to connect with online and in-store shoppers, driving brand awareness and boosting conversions through digital signage and its popular SmartRewards loyalty program.

Second CDR/MMR breakfast at NACDS Annual looks at Nourishing Change Conference
Colleen Lindholz also talked about the Food as Medicine movement, and the need to change the way health care is delivered in America.